Back to Search
GENE PRENDERGAST, D.O.
D.O.
Orthopaedic Surgery Physician
NPI: 1144370446IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
A-1607-11(NM)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
OTHER
Class of 1979
Research & Publications (20)
The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.
PMID 19494274·J Immunol·2009
7-preclinical
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.
PMID 19476837·J Am Coll Surg·2009
8-other
BAR the door: cancer suppression by amphiphysin-like genes.
PMID 18930786·Biochim Biophys Acta·2009
6-review
The relative magnitude of the effects of biological and physical settlement cues for cypris larvae of the acorn barnacle, Semibalanus balanoides L.
PMID 18846458·Biofouling·2009
7-preclinical
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
PMID 18318466·J Med Chem·2008
7-preclinical
Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging.
PMID 18339847·Cancer Res·2008
7-preclinical
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
PMID 18364004·Immunol Rev·2008
6-review
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
PMID 18665584·J Med Chem·2008
8-other
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
PMID 18952840·Proc Natl Acad Sci U S A·2008
7-preclinical
Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration.
PMID 18180298·J Biol Chem·2008
7-preclinical
Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
PMID 19004406·J Reprod Med·2008
8-other
Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer.
PMID 18237448·BMC Med Genomics·2008
8-other
A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.
PMID 18806825·Oncogene·2008
8-other
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
PMID 18026137·Oncogene·2008
7-preclinical
Field-based video observations of wild barnacle cyprid behaviour in response to textural and chemical settlement cues.
PMID 18696291·Biofouling·2008
7-preclinical
Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer.
PMID 17699764·Cancer Res·2007
7-preclinical
mDia function is critical for the cell suicide program triggered by farnesyl transferase inhibition.
PMID 17786040·Cancer Biol Ther·2007
7-preclinical
RhoB regulates PDGFR-beta trafficking and signaling in vascular smooth muscle cells.
PMID 17951322·Arterioscler Thromb Vasc Biol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4485 S 1-19 FRONTAGE ROAD, SUITE 100
GREEN VALLEY, AZ 85614 - Phone
- (866) 974-2673
Quick Facts
- NPI
- 1144370446
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile